The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)

NCT00279201 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2091

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin glargine
DRUG: Lispro Low Mix
DRUG: Lispro Mid Mix
DRUG: Lispro

Sponsor

Eli Lilly and Company